Correlation Between Pfizer and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both Pfizer and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Moleculin Biotech, you can compare the effects of market volatilities on Pfizer and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Moleculin Biotech.
Diversification Opportunities for Pfizer and Moleculin Biotech
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pfizer and Moleculin is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Pfizer i.e., Pfizer and Moleculin Biotech go up and down completely randomly.
Pair Corralation between Pfizer and Moleculin Biotech
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Moleculin Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 7.66 times less risky than Moleculin Biotech. The stock trades about -0.05 of its potential returns per unit of risk. The Moleculin Biotech is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 1,031 in Moleculin Biotech on January 16, 2025 and sell it today you would lose (939.00) from holding Moleculin Biotech or give up 91.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Moleculin Biotech
Performance |
| Timeline |
| Pfizer Inc |
| Moleculin Biotech |
Pfizer and Moleculin Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Moleculin Biotech
The main advantage of trading using opposite Pfizer and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.| Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |